Berlin-based DasLab has raised €6.2 million in a seed funding round as it aims to help the telemedicine industry add diagnostic testing and results into their product lineup. The funding will be used to further develop the platform and expand both the partner network and team size.
While initially focusing on PCR, antigen, antibody tests, and vaccines, the funding will also allow DasLab to expand its offer to include a much broader spectrum of tests that patients can perform themselves at home and have analysed by accredited medical laboratories.
According to the CDC, “14 billion laboratory tests are ordered annually,” and, “70% of today’s medical decisions depend on laboratory test results.” Yet, often vendor-specific specific limitations lead to a fragmented, disconnected, and inconsistent ecosystem.
In offering a vendor-neutral approach, DasLab is aiming to cut through the red tape. With a two-pronged approach, the startup offers healthcare providers access to a platform that sees diagnostic testing and results added to their list of services, while at the same time increasing test volumes for partnered laboratories.
Since launching in late 2020, DasLab has seen some 600,000 test results pass through its doors via 50+ partners at 150 sites in Germany and Spain.
“We see ourselves as an innovative co-creator of the digital health ecosystem. Our vision is to create a 'plug-and-play' solution for digital health providers, labs and other platform partners. We empower patients with our platform to take their health into their own hands and to be able to access and share their test results digitally at any time," explains DasLab CEO and co-founder Dr. Daniel Fallscheer.
DasLab’s €6.2 million seed funding round was led by Speedinvest with KAYA Ventures, All Iron Ventures, and Plug and Play participating. Also joining the round, DasLab received support from a number of European medtech entrepreneurs including the founders of Ada Health, caresyntax, Doctoralia, myoncare, and medneo.
“The pandemic has clearly shown the current lack of data transfer and security standards of the partly analogue processes and the strong fragmentation of patient data. For precise diagnostics and individualised therapies, relevant data must be available quickly, consistently, and securely - for the physician and the patient,” commented caresyntax founder and DasLabs investor Björn von Siemens.